ProALL Blood Trial Presented at ASH 2016 Conference

Curewize presented results of our retrospective clinical trial showing the correlation of ProALL microRNA in blood to microRNA in Bone Marrow at the 58th Annual Meeting and Exposition of the American Society of Hematology in San Diego December 2016. The Poster presented by Curewize's team "Mir Expression Profile of Peripheral Blood Lymphocytes Predicts Relapse in Pediatric Acute Lymphoblastic Leukemia", Avigad et al., Blood 2016, 128:1736. Results show the feasibility of developing the ProALL blood test. Our prospective clinical for the blood test is underway.